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Nanomaterials have high potential as powerful tools for nanomedicine in a wide range of most promising
applications as highly specific devices for diagnosis and therapy. Yet, despite enormous research activ-
ities in the design and synthesis of nanomaterials for biomedicine, only a small number of those have
made their way to clinical use. The unavoidable formation of a biomolecular adsorption layer, the ‘protein
corona’ or ‘biomolecular corona’ around nanoparticles (NPs) has been recognized as a major roadblock on
the way toward the efficient design of nanomedicines. It masks the generic NP properties and creates a
new ‘biological identity’ that largely controls the interactions with the biological environment. Therefore,
for successful design of nanomedical devices, researchers must anticipate formation of this protein
adlayer and its ensuing effects. In this review, we summarize our current knowledge in the field and
focus on three topics that appear to be important for furthering progress in our ability to predict in-vivo
responses to NP incorporation from in-vitro studies. First, we address fundamental physicochemical is-
sues of protein corona formation as revealed by recent in-vitro studies, with a focus on the underlying
mechanistic details. Second, we illustrate with recent examples how our present, still incomplete un-
derstanding can already be exploited to control protein corona formation in the organism, including
important processes involving the immune system. Third, recent advances in the transition from in-vitro
to in-vivo studies of protein adsorption will be summarized, which is obviously a key step in NP
development for nanomedicine. We conclude this review with an outlook on possible future de-
velopments in the field.
© 2019 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Studies of interactions of artificial bulk materials with bio-
molecules have a long-standing history due to their importance for
the development of biocompatible medical devices, e.g. catheters,
joint replacements, or stents [1]. Recent years have witnessed
enormous efforts to investigate such interactions with engineered
nanomaterials, driven by the realization that these devices offer
unprecedented capabilities as tools in biomedical research, di-
agnostics and therapy [2]. For example, a wide range of nano-
particles (NPs) have been developed as luminescence markers
with specific targeting capabilities for optical imaging, or contrastier Ltd. This is an open access articagents for computer tomography or magnetic resonance imaging
[3e7]. Another most exciting field is the design of nanocarriers
that deliver drugs to specific cell types, e.g. in cancer therapy
[2,3,8,9].
NPs for biological applications have been synthesized in a vast
variety of ways from a broad palette of materials [2,10]; they come
in many different sizes and shapes and can vary widely in their
physicochemical properties (Fig. 1). Frequently, inorganic cores are
coated with surface ligands, endowing the NPs with colloidal sta-
bility and functional groups for specific targeting of proteins and
other biomolecules. Like bulk materials, NPs typically possess sur-
faces that are reactive toward biomatter, and when they are
exposed to biological fluids containing biological macromolecules
(biofluids), e.g. cell-culture media in in-vitro studies or blood upon
intravenous injection, their surfaces become rapidly covered by
dissolved components, in particular proteins. The catchy notionsle under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Fig. 1. The nano-bio interface. Nanoparticles have been synthesized in different shapes and sizes from various materials and are often further modified by surface functionalization.
The physicochemical properties of the NP surfaces greatly affect protein adsorption and thereby control the properties of the biomolecular corona, which mediates the interaction
between nanomaterials and the biological environment. The physical nature of the corona depends on the detailed history of the biofluid exposure (e.g. in vitro vs. in vivo), the type
of organism and even the health status of a patient.
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(to acknowledge the presence of other biomolecules, e.g. lipids and
carbohydrates) have been coined to describe this adsorption layer.
It conceals the ‘physicochemical identity’ of the pristine NPs and
confers a ‘biological identity’ to the NPs because cells within an
organism interact with this adlayer rather than the NP surface,
mainly via receptor proteins resident in the plasmamembrane [12].
Accordingly, any attempt to engineer NPs for biomedical applica-
tions must take this inevitable modification into account. The
processes occurring during formation of this interfacial layer are
exceedingly complicated, however, and even fundamental issues
are still under debate.The physical nature of the protein corona is largely governed by
the (surface) properties of the NPs and by the types and (relative)
amounts of biomolecules (and their individual properties) present
in the biofluid [13e16]. Moreover, it is affected by external factors
such as incubation time, temperature, shear forces due to flow (e.g.
in vitro in reactors or in vivo in the bloodstream), and may even
reflect the history of the entire trajectory taken by a NP migrating
through different compartments of an organism [12,17e20]. For
any biomedical application of NPs, e.g. as drug carriers, it is crucially
important to understand corona formation at the molecular level,
so that it becomes possible to control and predict its effects on the
biological environment [21].
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NPs for biomedical applications and the implications of protein
corona formation for NP engineering [12,22e27]. Here we have not
aimed at contributing yet another exhaustive review. We instead
focus on three different areas that deem particularly important for
further advancement of NPs for biomedical applications. After a
brief sketch introducing important aspects of the protein corona,
we first address fundamental physicochemical issues of protein
corona formation, which have been explored in in-vitro studies,
with a special focus on the underlying mechanistic details. Second,
we present recent examples of how a molecular-scale under-
standing can be used to control the nature of the protein corona,
enabling the engineering of NPs with advantageous properties for
nanomedicine applications. Third, we discuss the transition from
in-vitro to in-vivo studies of protein adsorption, which is a key step
in the translation from nanomaterials to nanomedical devices.
Finally, we discuss ongoing challenges and give an outlook on
research directions that may help enhance the effectiveness of the
development of NPs for diagnostics and therapy.
2. Facts and views about the nature of the protein corona
2.1. Current views of the protein corona
Upon immersion in a biological fluid, NPs randomly collide with
proteins and other biomolecules. Protein association with NP sur-
faces will be stabilized by formation of enthalpic (covalent, elec-
trostatic, van-der-Waals, hydrogen bond) interactions; further
important stabilizing contributions come from entropic effects
(liberation of small molecules from the joining surfaces, configu-
rational entropy changes of the proteins) [28,29]. Processes occur-
ring upon corona formation include fast reversible protein binding
and unbinding events, NP-protein interactions triggering confor-
mational adaptations especially of the proteins and possibly also of
the NPs. Protein-protein interactions can modulate these structural
changes and they can also lead to displacement of a protein by a
more strongly adhering one. Moreover, protein adsorption can
enhance NPeNP interactions, cross-linking NPs and generating
agglomerates. It is evident that formation of NP clusters can have
detrimental effects for the usefulness of nanomedicines.
A wealth of papers has been published reporting experimental
investigations of in-vitro protein corona formation, revealing de-
pendencies on: (1) the physicochemical nature of the NP surface;
(2) the unique structural, dynamic and energetic properties of
biological macromolecules, especially proteins; and (3) external
parameters including temperature, shear forces, protein concen-
tration and pH [23,25,30e32]. The initial adsorption of proteins is a
concentration-dependent process and happens on fast (subsecond)
time scales in typical biofluids. Subsequently occurring structural
adaptations at the interface, involving the proteins and possibly
also the NPs, may be much slower and can lead to very strong
binding that is irreversible on any relevant time scale. These pro-
cesses are already difficult to capture in experimental studies with
simplemodel biofluids (protein solutions), but in real biofluids such
as blood plasma, there are ~3700 proteins and other small mole-
cules [33], all with different adsorption behaviors, competing for
binding sites on the NPs. For example, a rigid yet weakly interacting
NP surface may induce only minor structural adaptations in the
proteins, reducing the binding free energy but keeping the overall
protein intact. Strongly reactive surfaces, in contrast, may induce
major protein conformational changes and can cause complete loss
of native protein structure [34e36]. Thus, depending on the nature
of the NP surface and possibly also of the proteins, the adsorption
process can result in very different outcomes, and general conclu-
sions cannot be drawn from a particular example. The notions of‘soft’ and ‘hard’ coronae, have been introduced to capture the
heterogeneity in the strengths of NP-protein interactions [12], as
indicated by kinetic or equilibrium parameters. A weakly interact-
ing, soft corona exists as long as the NPs are in equilibriumwith the
biofluid; it is quickly lost, however, after separation of the NPs from
the immersion medium. In contrast, a hard corona refers to a
persistent polypeptide layer that withstands extensive rinsing. A
real protein corona may include soft and hard components. To
rationalize this fact, multilayer models have been proposed, in
which the hard corona is surrounded by a soft corona or even
‘protein clouds’ [25,37,38]. However, although the hard/soft di-
chotomy is practical from the viewpoint of experimental studies, a
protein-decorated NP surface may display a wide and continuous
spectrum of binding strengths, with weakly and strongly binding
sites and everything in between. Notably, this does not necessarily
require the presence of multilayer structures.
Strictly speaking, in the presence of widely differing protein
adsorption affinities, the complete protein corona can only be
studied with in-situ experiments, measurements on NPs while
they are being exposed to the biofluid. Whenever the NPs are
separated from the biofluid, weakly binding proteins will disso-
ciate. Are more weakly bound proteins irrelevant for eliciting
biological responses? Not necessarily e a highly abundant pro-
tein with its higher association rate can populate even a weaker
binding site to a high degree. The hard component of the corona
has been the focus of most experimental investigations in the
field, however, because it can be studied more easily due to its
quasistatic (slowly evolving) nature. After immersion in bio-
fluids, e.g. blood serum or plasma, protein-coated NPs are
separated from the dissolved protein fraction by washing, and
the tightly adherent polypeptide layer can be resolubilized under
harsh conditions (buffers containing sodium dodecyl sulfate
(SDS), dithiothreitol (DTT), urea and 95 C) and subjected to
proteomic analysis by, e.g. gel electrophoresis or liquid chroma-
tography coupled to tandem mass spectrometry (LC-MS/MS),
which allows the types and relative abundances of the adsorbed
peptide chains to be determined [25]. Proteomics analyses have
revealed the protein compositions of the NP coronae and their
dependencies on NP properties including size, charge and
chemical functionalization [19,25,39,40]. In view of the widely
differing binding strengths of proteins to NPs, it is not surprising
that details of the separation procedures can have a strong effect
on the results [41]. Typically, hundreds of different types of
adsorbed polypeptide chains are identified in the adsorption
layer, often more than the number of proteins that can fit onto a
single NP. Importantly, this observation does not indicate that
there are “multiple core-shell structures or higher order Christ-
mas tree-like structures [25],” but rather points to a fundamental
statistical problem. Bulk proteomic analysis reveals the protein
composition as an average over a NP ensemble [42]. Thus,
considering that thousands of proteins in serum or plasma
compete for a tiny surface area, offering room for typically a few
ten to a few hundred proteins, there will necessarily be large
statistical variations in protein composition within the NP
ensemble. Therefore, if only a subset of the NP ensemble dis-
playing a particular protein decoration induces a biological
response, knowledge of the average composition is not sufficient.
Recently, Maurizi and coworkers [40] investigated the signifi-
cance of a proteomics analysis of serum protein adsorption onto
functionalized silica beads (with iron oxide cores). By repeating
the experiments three times, they found that 60% of the identi-
fied corona proteins were statistically insignificant. Still,
although it appears that some technical issues deserve further
attention, proteomics analyses are exceedingly powerful for
protein corona exploration.
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Hard coronae are believed to develop within seconds. In fact,
formation of a persistent protein layer has been observed after
30 s immersion of NPs in human blood plasma [19]. However, the
structure and composition of the corona may still continue to
change for hours or days. There are only a few experimental
studies aimed at elucidating structural changes during the long-
time evolution of the protein corona [35,37,43e45]. For
example, Piella et al. [43] have tracked the red shift of the
localized plasmon resonance band of citrate-stabilized Au NPs by,
which reports an increase of the refractive index and/or covalent
bond formation between the Au NP and the polypeptide chain
(especially via cysteine, histidine, or lysine sidechains). Usually,
the slow evolution of the protein composition in the corona is
explained as a transition from an early non-equilibrium state
toward thermodynamic equilibrium, referred to as the ‘Vroman
effect’ [46]. The initial composition of the corona is governed by
(bimolecular) association rates, which depend on the concentra-
tions of different proteins in a biofluid and, to a lesser extent, on
their diffusional properties. Subsequently, the adlayer relaxes to
an equilibrium protein composition by exchange of fast-binding
proteins with more strongly binding ones. Evidently, this simple
model does not account for other important effects due to
protein-protein and protein-surface interactions [47]. Thus, one
should not be too surprised to find experimental results that are
at odds with the simple Vroman mechanism [47,48]. Moreover, it
appears feasible that approach to equilibrium, which is e ac-
cording to the physicist R. Feynman e when “all the fast things
have happened but the slow things have not” [49], may be
completely suppressed under given conditions. For example, a
densely grafted layer of proteins may be able to prevent access of
more strongly binding proteins to the surface on all relevant
experimental time scales, so equilibration will not be observed.
This example also shows that it is crucially important to obtain a
better understanding of the molecular level structure of the
protein corona. The corona around NPs migrating through
different compartments of an organism may never reach equi-
librium because of the concomitant change of biofluid composi-
tion between those compartments. In fact, it has been suggested
that the protein corona may keep signatures of its entire history
of formation [32].
2.3. Characterization of the protein corona
There are a wide variety of analytical techniques available for
protein corona characterization. In general, they offer only limited
views, and complementary techniques should be combined to
analyze different aspects. Importantly, methods for nanoscale
characterization are often sophisticated and require considerable
technical skills to produce meaningful results. Extensive de-
scriptions of available techniques, including their advantages and
disadvantages, have been compiled in recent reviews [50e57]. In
the following, we only briefly mention a selected set of methods
relevant to the topics of this review.
Mass spectrometry (MS) is a highly sensitive method that al-
lows the identification of protein types in a mixture [58]. Thus, it
has been widely employed to identify different kinds of poly-
peptide chains adsorbed onto NPs ex situ, i.e. after separation of
the NPs from the immersion fluid. Among the MS variants, liquid
chromatography-MS (LC-MS) has become the method of choice
for qualitative and quantitative determination of the types of
proteins in the hard corona [19,59]. This is crucial information but
does not reveal how the polypeptide chains are physically ar-
ranged on the NP surface, which is indispensable for a detailedunderstanding of the adsorption layer. Transmission electron
microscopy (TEM), scanning electron microscopy (SEM), and
atomic force microscopy (AFM) can provide (usually) ex-situ im-
ages of NPs coated with adsorbed proteins. For in-situ measure-
ment of NPs immersed in the biofluid, techniques that quantify
translational diffusion of NPs have been widely employed, espe-
cially dynamic light scattering (DLS) [60], but also fluorescence
correlation spectroscopy (FCS) [61], nanoparticle tracking analysis
(NTA) [62] and diffusion-ordered nuclear magnetic resonance
spectroscopy (DOSY-NMR) [63]. These techniques have in com-
mon that they reveal diffusion coefficients in the biofluid, from
which hydrodynamic radii can be calculated via the Stokes-
Einstein relation. Thus, the protein corona thickness can be
determined from the radius increase due to protein adsorption as
a single structural parameter, averaged over the whole ensemble.
This is a small yet important piece of structural information.
Furthermore, there are spectroscopic techniques sensitive to the
conformation of the adsorbed proteins. Secondary structure can
be analyzed via the circular dichroism (CD) spectrometry of the
peptide bond resonance in the ultraviolet (UV) region [35,64], and
by Fourier transform infrared (FTIR) spectrometry in the amide
vibrational bands of the peptide group [65,66]. Fluorescence
spectroscopy of the near-UV tryptophan bands reveals their sol-
vent accessibility, which typically changes upon unfolding.
Evidently, all these techniques are insensitive in the presence of a
protein-rich biofluid due to its overwhelming contribution to the
total signal and, therefore, are preferentially applied ex-situ. They
give only an average assessment of the corona properties and do
not reveal heterogeneities in the NP surface decoration, which are
expected for protein adsorption from complex biofluids and may
affect the in-vivo behavior, including the NP biodistribution and
safety [67].
In recent years, sophisticated new experimental methods have
been introduced for the study of structural aspects of protein
adsorption onto NPs. Importantly, fluorescence-based optical mi-
croscopy techniques [68,69] offer nanometric resolution and/or
single molecule sensitivity, and enable the direct visualization of
biomolecular adsorption at the level of individual NPs and proteins,
so that ensemble averaging is avoided. However, they require
fluorescence labeling and thus are preferably applied in simplified
model studies. Landes, Link and coworkers [34] have observed the
adsorption, unfolding and spreading of albumin on Au nanorods
and studied the resulting effects on NP aggregation. In other
studies, single molecule localization microscopy of proteins
adsorbing onto NPs has been used to analyze the formation and
time evolution of the protein corona [70e73]. F€orster resonance
energy transfer (FRET) spectroscopy is a powerful method for
structural studies of the protein corona with nanometric resolution
[74]. Raoufi et al. [75] used FRET to monitor the conformation of
fibronectin on corona-coated Au NPs. Single-molecule sensitivity
can also be achieved by label-free approaches that rely on single
molecule detection using plasmonic metal nanostructures as a
sensing platform [76,77]. For example, surface-enhanced Raman
scattering (SERS) uses the huge amplification of Raman scattering
that occurs only within a few nanometers from a plasmonic NP and,
thus, can be used for in-situ studies [78,79].
The steady growth of computational power is likely to further
spawn computer simulations aimed at modelling molecular dy-
namics at the nano-bio interface [80]. Computer simulations of
protein adsorption are still at an early stage but have already pro-
vided valuable atomic-scale insight into early steps of protein
structural changes upon adsorption to artificial surfaces [80e87];
the ensuing, slower unfolding processes and rearrangements in the
adsorption layer, however, have not yet been simulated due to the
large systems and long times involved.
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formation
3.1. NP properties
A wide variety of NPs have been synthesized from many
different materials, giving rise to widely different interfacial prop-
erties that govern the reactions with biomolecules (Fig. 1). Much
insight into these interactions has already been gained from studies
of proteins with bulk surfaces dating back to the 1960s and 1970s,
revealing how parameters such as surface free energy, morphology,
charge and hydrophobicity affect the protein adsorption process
[48,88,89]. By virtue of their size, NPs feature new and distinct
properties that have to be taken into account. As NP dimensions
approach the atomic scale, NP surface properties become inevitably
heterogeneous. Inorganic NPs are mostly small crystals, and their
surface properties depend on the exposed crystalline facets, edges
and vortices, the presence of surface defects, and the structures can
be unstable and prone to reconstruction. For biological applica-
tions, the crystalline NP cores are typically coated with ligands
bearing, e.g. carboxyl, amine or other groups, which endow them
with chemical and colloidal stability. A coating with polymeric li-
gands such as polyethylene glycol (PEG) can provide hydrophilic
and protein-repellant properties [90,91].
Polymeric NPs comprise a class of highly versatile NPs that may
feature outstanding biodegradability and biocompatibility [92]. In
many cases, they consist of a hydrophobic core-forming polymer
and a shell-forming polymer (typically charged or hydrophilic),
which may be functionalized with targeting and/or protein-
repellant moieties. To enhance the overall stability of the NPs, the
core and/or shell polymers can be crosslinked. The linkers between
core and shell or shell and functional groups can be utilized to
introduce responsiveness (i.e. assembly/disassembly) towards in-
ternal stimuli such as pH, enzymatic or reductive/oxidative condi-
tions of the bioenvironment or external parameters such as
temperature changes, light irradiation, or ultrasound [93,94].
Widely used synthetic polymers are poly(lactic acid) (PLA), poly(-
glycolic acid) (PGA), PLA-PGA copolymers, polycaprolactones (PCL),
and polyacrylates such as poly(cyanoacrylate) (PCA). Alginate, al-
bumin, and chitosan are among the most widely explored natural
polymers [95].
Lipid-based particles, called liposomes, were described as early
as 1965 [96] and soon afterwards proposed as drug delivery sys-
tems [97,98]. In the meantime, small liposomes with diameters of
~100 nm have evolved into a well-studied class of drug carriers
consisting of a lipid bilayer that is primarily composed of amphi-
pathic phospholipids enclosing an interior aqueous space loaded
with a chemotherapeutic agent [99,100]. A PEGylated liposome-
based formulation of the anticancer drug doxorubicin, Doxil, was
the first NP-based drug approved for clinical application [101]. Li-
posomes can be engineered to have a high drug-to-lipid ratio,
excellent retention of the encapsulated drug, and a long (>6 h)
circulation lifetime, which facilitates their accumulation at target
sites such as tumors, where the endothelial layer is ‘leaky’ and al-
lows extravasation of small particles [102].
For biomedical applications, reliable bulk production of highly
defined, i.e. monodisperse and colloidally stable NPs with minimal
heterogeneity of surface properties (surface chemistry, charge,
morphology), is a key requirement [67]. Although atomically pre-
cise NPs have been synthesized [103,104], most NPs in use are
heterogeneous in size, density of surface functionalizing groups
and other properties [105,106]. In addition, precise characterization
of the physicochemical properties of NPs at the nanoscale is far
from being a routine procedure. To this end, many techniques have
been made available [56], but their application can be challengingand require considerable experience [55]. New analytical methods
are under continuous development [34,61,107], and progress in this
area will be essential to further advance the field.
3.2. Protein properties
Proteins are linear polymer chains made from 20 different
amino acids that fold (often spontaneously) into specific, bioactive
3D structures in the proper environment. They are flexible mac-
romolecules with a large inherent structural complexity [108],
which is often essential for their biological function. Proteins are
thermodynamically only marginally stable; the stabilization free
energy of a small protein consisting of several thousand atoms
typically amounts to the equivalent of only a few hydrogen bonds
[109]. Moreover, thermodynamic stability can differ considerably
among proteins, affecting their structural responses onto artificial
surfaces [110,111]. In globular proteins, hydrophobic and hydro-
philic amino acid residues are preferentially located in the interior
and on the surface, respectively. In fact, sequestration of hydro-
phobic residues into the core is a key driving force for folding. The
presence of polar (neutral and positively or negatively charged)
residues on the protein surface ensures their high colloidal stability.
The charge state of a particular protonatable residue depends on
the pH and its local electrostatic environment. The overall protein
charge and its charge distribution can be changed by pH variation
within a considerable range, outside of which the protein unfolds.
Charge modification can strongly affect NP-protein and protein-
protein interactions [112,113], and can be exploited for the design
of protein adsorption layers. Larger proteins typically consist of
several domains, individually folding subunits that are arranged
like beads on a string. Thus, in a multidomain protein such as an
immunoglobulin (Ig), a particular domain may unfold due to sur-
face interactions, while others still retain their native 3D architec-
ture and functional properties.
3.3. NP-protein interactions
In general, NP-protein interactions can cause modifications of
the physicochemical properties of both NP and protein. Structural
changes (reconstruction) of small crystalline NPs or removal of
solubilizing ligands (e.g. citrate on Au NPs, surfactants on polymer
NPs) can occur upon protein adsorption, and charge compensation
due to protein adsorption can compromise the colloidal stability of
electrostatically stabilized NPs. Proteins inevitably change their
structure upon adsorption if the internal forces that stabilize the 3D
architecture are weaker than the interactions with the NP surface.
Then, the polypeptide chain abandons its native fold in order to
establish optimal interactions with the NP surface. These structural
adaptations are exceedingly complex and can completely change
the nature of the polypeptides. Notably, partial or complete
unfolding on a NP surface can expose the hydrophobic core of a
protein globule and render the unfolded polypeptide chain much
less hydrophilic than the original folded species, compromising the
colloidal stability in aqueous solutions.
Due to their complexity, the structural adaptations induced by
NPeprotein interactions cannot be predicted. They depend on the
physical nature of the NPs and proteins and, to a great extent, on
the external conditions (temperature, pH, concentration, flow
conditions) [23,25,30e32]. In fact, the notion of a protein corona
appears unfitting when referring to an assemblage of completely
unfolded polypeptide chains on a NP surface. This lack of detailed
information about the molecular-level structure of the adsorption
layer is one of the key impediments to an in-depth understanding
of the protein corona; colorful schematic depictions of the
adsorption layer (Fig. 1) [12,25,27,38,114e116] are no substitutes for
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experiments such as circular dichroism (CD) spectrometry and
Fourier transform infrared (FTIR) spectroscopy reveal secondary
structure alterations upon protein adsorption, but this is a very
limited piece of information. NP sizing experiments, based on the
precise quantification of NP translational diffusion, are conceptu-
ally simple and yield the corona thickness as a simple yet important
structural parameter. Model experiments with simple biofluids
such as solutions of purified proteins and well characterized NPs
can provide general insight into the adsorption process.
3.3.1. In-situ model studies of corona formation on hydrophilic NPs
To explore the structure of the protein corona, we have used
particle sizing experiments based on FCS to measure the NP size
increase (with subnanometer resolution) due to protein adsorption
while small (5e10 nm) and fluorescent NPs were immersed in
phosphate-buffered saline (PBS) solutions containing a single type
of protein. As a representative example, Fig. 2 shows data of human
serum albumin (HSA) adsorption onto CdSe/ZnS quantum dots
(QDs) with systematically varied surface ligands, negatively
charged dihydrolipoic acid (DHLA), zwitterionic D-penicillamine
(DPA), and PEG end-functionalized with cationic amino groups
[117]. Each data point represents a single experiment, in which the
NP size was measured in the HSA (in PBS) immersion fluid of the
indicated concentration (10 min incubation). For PEG-coated NPs,
no change of the NP size is visible over the entire HSA concentrationFig. 2. Protein adsorption onto (a, b, c) DHLA-QDs, (d, e, f) DPA-QDs, and (g, h, i) PEG-QD
Schematic depictions of QDs (green spheres) with their coating layers (gray) and the serum
plotted as functions of serum (black) and HSA (gray) concentration, respectively; solid lines
three independent measurements. Green and purple symbols mark the concentrations sel
(purple) or half (green) corona by immersion in serum solution of the marked concentrat
Dilution factors: (c) DHLA-QDs, 32-fold (purple), 4-fold (green); (f) DPA-QDs, 23-fold (purpl
from three independent measurements. Adapted from Ref. [117].range, attesting to the protein-repellant effect of PEG. For DHLA-
and DPA-coated NPs, the size increases smoothly up to a saturation
level, in accord with an equation based on the Langmuir adsorption
isotherm or, more generally, a Hill isotherm, which includes an
additional steepness parameter to capture binding cooperativity
(protein-protein interactions) [118,119]. This functional form is
theoretically based on a simple adsorption/desorption equilibrium.
Reversible protein adsorption was tested with concentration jump
experiments. Like other relaxation methods such as temperature or
pressure jump, this approach can reveal whether a dynamic equi-
librium exists and allows, in principle, the kinetic coefficients to be
determined [120]. The protein concentration was changed in situ
(up or down), resulting in a concomitant RH change as predicted by
the isotherm, proving reversibility of protein adsorption. Needless
to say that those ‘soft’ coronae can only be studied in situ; every
attempt to isolate the protein-enshrouded NP from the solutionwill
quickly lead to protein desorption. We have found Langmuir/Hill
isotherms without a single exception for a wide selection of serum
proteins adsorbing onto a range of small model NPs with diverse
surface ligands [112,121e123].
Quantitative analysis of the protein concentration dependence
of the hydrodynamic radius, RH, yields the corona thickness, DRH, a
midpoint protein concentration, K0D, which is a measure of the
binding affinity, a Hill parameter n, and an estimate of the
maximum number of protein molecules, Nmax, that fit into the
volume of the protein adlayer [118]. With increasing HSAs immersed in human serum and HSA dissolved in PBS (10 min incubation). (a, d, g)
protein coronae. (b, e, h) Hydrodynamic radii of QDs, determined by using FCS, are
represent fits based on the Hill equation. Error bars indicate standard deviations from
ected for the dilution experiments. (c, f, i) Dilution experiments after preparing a full
ions. The QD sizes were measured before (at time 0) and after quantitative dilution.
e), 4-fold (green); (i) PEG-QDs, 64-fold (purple). Error bars denote standard deviations
K. Nienhaus et al. / Materials Today Advances 5 (2020) 100036 7concentration, RH increases by ~3 nm in a single step (Fig. 2b,e),
indicating that the HSA molecules form a monolayer around the
NPs. The HSA fold resembles an equilateral triangular prism with
8.4 nm edges and 3.2 nm thickness (pdb code 1UOR); therefore, the
thickness implies that HSA molecules adsorb with one of their
triangular faces. Different corona thicknesses were found for
differently charged NPs and (charge-modified) HSA, indicating that
HSA can assume specific orientations on the NP surface, depending
on the experimental conditions [112]. A clear relation between
monolayer thickness and the known protein dimensions was also
found for other serum proteins, including apolipoprotein E4,
apolipoprotein A-I, and apotransferrin (Tf) adsorbing onto FePt NPs
[122] and apolipoprotein E3 and complement component 3 (C3)
interacting with carboxyl-functionalized and lipid-coated QDs
[123], suggesting that all these proteins adsorbed onto the NP
surfaces as monolayers with a preferential orientation. HSA and Tf
monolayers were also found on much larger (RH ~50 nm) carboxyl-
functionalized, hydrophilic polystyrene (PSeCOOH) NPs [124],
whereas other studies reported multilayer coronae on relatively
‘flat’ nanomaterials, e.g. nanorods or larger NPs [43,115,124e127].
Comparison of the binding affinities, quantified by KD, of
different proteins to model NPs revealed the important role of
charge interactions on the protein surfaces mediating the interac-
tion. The KD values were widely different (0.02e37 mM [121]),
depending on the particular NP-protein combination. They were,
however, not governed by the net charges of the NPs and the
proteins but rather by electrostatic interactions between localized
charged patches on the protein and NP surfaces [121,122]. At typical
ionic strengths of biological media (~150 mM), Debye screening is
efficient, limiting charge interactions to distances <1 nm, which
explains why NP-protein association is mediated by local charge
patterns on the NPs and proteins rather than overall charges.
Experiments with hydrophilic NPs and a complex biofluid, i.e.
blood serum, revealed similarities but also important differences to
themodel studies described above (Fig. 2). Again, the concentration
dependence followed binding isotherms, saturating at a size in-
crease of a few nanometers, suggesting formation of a protein
monolayer. Notably, there are apparently proteins in blood serum
that, unlike HSA, are able to adsorb onto PEGylated NPs (Fig. 2g and
h). For the examples shown, we observed thin coronae of only a few
nanometer thickness, compatible with monolayers. Importantly,
although the adsorption curve followed an equilibrium binding
isotherm, the serum proteins adsorbed irreversibly, as confirmed
by concentration jump experiments (Fig. 2c, f, i). Thus, it was
possible to separate the protein-coated NPs from the serum to
identify the adsorbed proteins by mass spectrometry. The exact
reasons for the strong binding of proteins from serum are yet to be
explored. Obviously, serum contains a vast number of proteins with
widely different properties, some of which may adhere very tightly
to the NPs, possibly due to unfolding. There could also be cooper-
ative interactions between different types of proteins (including
opsonization reactions) that can cause these effects.
3.3.2. In-situ studies of corona formation on large, hydrophobic NPs
Recently, we extended our protein adsorption studies to large
PS-OSO3H NPs (RH ~50 nm) [72]. Polystyrene (PS) NPs, sparsely
functionalized with sulfate (PSeOSO3H NPs) for electrostatic
colloidal stabilization in aqueous solution, have extremely hydro-
phobic surfaces covered with benzene moieties and are popular
model NPs for nano-bio studies [14]. Their non-polar surfaces
adsorb proteins more strongly than polar surfaces and tend to
severely destabilize and unfold proteins, which leads to effective
NP-protein and protein-protein interactions. In addition, the
strongly acidic sulfate groups may also play a role in the adsorption
process [128]. For in-situNP sizing experiments, we used DLS ratherthan FCS because the strong scattering contribution from large NPs
is well separable from the one of the much smaller proteins. For
small NPs, this is not the case and FCS offers clear advantages if the
analysis is based only on the fluorescence of the NPs, as the (non-
fluorescent) proteins are invisible. We selected Tf and HSA for our
studies onto these NPs because they had already been widely
employed in other protein adsorption studies.
Whereas the concentration dependence of Tf adsorption onto
carboxyl-functionalized, hydrophilic PS NPs (PSeCOOH NPs, RH
~35 nm) showed the usual adsorption isotherm discussed in the
previous subsection, a completely different behavior was found
with PS-OSO3H NPs (in regular phosphate buffered saline (PBS)
solvent, Fig. 3a and b) [72]. The observed size changes were all due
to irreversible adsorption of Tf to the hydrophobic surfaces, as
confirmed by concentration jump experiments (Fig. 3a and b). In
very dilute (subnanomolar) Tf solutions, the overall size of the NPs
(0.7 nM) increased moderately with increasing Tf concentration. At
intermediate concentrations, up to 1.6 mm large particles were
present. Total internal reflection fluorescence (TIRF) microscopy
(Fig. 3a, insets) revealed that these particles are NP agglomerates.
This tendency was already noticeable at very low Tf concentrations,
corresponding to a NP:protein ratio of roughly one to one. Conse-
quently, already a few Tf molecules (or even a single one) can act as
glue connecting the PS NPs. This protein-induced stickiness can e
in our view e only result from denaturation of the proteins and
subsequent adsorption of their hydrophobic moieties to two NPs.
These findings are in nice agreement with results by Link and co-
workers on protein-mediated crosslinking of Au nanorods [34].
However, T4 lysozyme was reported to trigger Au NP aggregation
while maintaining its native structure and activity [129]. Thus,
protein-induced aggregation may occur without denaturation,
depending on the thermodynamic stability and structural proper-
ties of the specific protein.
At 0.5 mM Tf, there is a remarkably sharp transition from
agglomeration to complete passivation against agglomeration
(Fig. 3a). Apparently, grafting the adlayer with a sufficiently high
protein concentration generates non-sticky surfaces, suggesting
that protein-protein interactions acting during adlayer formation
are responsible for the effect. As we argue in the next subsection,
conformational changes may be restricted under these conditions
so that the adsorbed proteins expose more hydrophilic surfaces
that prevent agglomeration. Above the passivation transition and
up to the highest Tf concentration (125 mM), there were individual
NPs, enshrouded by a protein corona of ~10 nm thickness, which is
compatible with a Tf monolayer [72]. Remarkably, despite the
constant thickness, the number of adsorbed Tf proteins increased
between 0.5 and 62.5 mM from 175 to 985 and thus more than
fivefold, as quantified by using dual-color single molecule locali-
zation microscopy. Therefore, the protein corona is by no means
very dense when prepared from a protein solution with a concen-
tration of ~1 mM. The constant corona thickness (Fig. 3a) in the
presence of largely varying protein numbers suggests that solvent
can form a major part of the protein layer. In fact, swelling of pro-
teins due to incorporation of solvent molecules is a typical phe-
nomenon observed in protein denaturation studies [130e132].
Apparently, in contrast to studies on reversibly adsorbed proteins,
the corona thickness does not scale with the number of adsorbed
proteins for these strongly denaturing NP surfaces.
The electrostatic stabilization of the PS-OSO3H NPs allows
variation of NP-NP repulsion by changing the ionic strength of the
solvent. Indeed, NP-NP repulsion is sufficiently high under reduced
charge screening, i.e. in 20-fold diluted PBS (0.05  PBS, pH 7.4), to
completely suppress agglomeration (Fig. 3c and d). The Tf con-
centration dependence of RH can again precisely be modeled by a
binding isotherm. However, decreasing the Tf concentration in situ
Fig. 3. Probing protein corona formation on PS-OSO3H NPs (RH~ 50 nm, 0.7 nM) by DLS. All measurements were performed after 10 min incubation. (a, b) Corona formation in PBS.
Black symbols: Tf concentration dependence of RH. The area under the curve is shown in gray. Colored symbols: RH measured before (closed symbols) and after 8-fold (open
symbols) (a) decrease and (b) increase of the Tf concentration (see arrows). Initial concentrations: 8 nM (blue), 61 nM (red), 0.49 mM (orange). Insets in (a): TIRF images of bare NPs
and after immersion in 61 nM and 0.49 mM Tf. (cef) Corona formation in 0.05  PBS. (c, d) Blue symbols: Tf concentration dependence of RH. The area under the curve is shown in
blue. Colored symbols: RH measured before (closed symbols) and after (open symbols) 64-fold (c) decrease and (d) increase of the Tf concentration, as indicated by the solid arrows.
Initial concentrations: 15.3 nM (magenta), 980 nM (green), 62.5 mM (purple). Dashed arrows in (d) indicate a 64-fold decrease after the initial 64-fold increase. (e, f) RH in 0.05  PBS,
measured as a function of time before (t ¼ 0) and after (e) decreasing and (f) increasing the Tf concentration 64-fold. Error bars indicate standard deviations from at least three
independent measurements. Lines mark the average RH. Adapted from Ref. [72].
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(Fig. 3c). Increasing the Tf concentration yielded an increase in
corona thickness, indicating that still more proteins can be loaded
onto the NP surface. Finally, there was no time evolution of the
corona thickness after the concentration jumps on time scales from
a few minutes to a few days (Fig. 3e and f).
All measurements discussed here have in common that the
observed coronae were only a few nanometers thick, which is
compatible with formation of protein monolayers. In view of the
fact that globular proteins, especially blood proteins, are
colloidally very stable, we are convinced that formation of thin,
essentially monolayer coronae on NPs is the rule [72,133]. By
contrast, protein coronae of several 10 nm have been reported
by DLS experiments and interpreted as multiple layers[43,126,134]. We note that large increases of the average hy-
drodynamic radius can also result from a small fraction of NP
agglomerates forming upon protein adsorption [124]. For
biomedical applications, colloidal stability of NPs in biofluids is
essential, and systematic studies of the effect are still scarce
[135,136]. For certain proteins, however, major structural
changes as those occurring during adsorption onto NPs may
trigger protein-protein association (e.g. via hydrophobic epi-
topes that become exposed due to denaturation) and fibrillation
[137,138]. Furthermore, components of the immune system
(antibodies, complement components) contained in blood serum
or plasma can attach themselves covalently or non-covalently to
the exposed protein surface of the corona and, thereby, form an
additional layer.
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implications for NP engineering
There is an important question raised by the data in Figs. 2 and
3. Why do wemeasure binding isotherms (Fig. 3c and d), which are
based on adsorption/desorption equilibria, even if protein adsorp-
tion is irreversible? A simple mechanistic model that involves two
sequential steps may help to give an explanation. NPs immersed in
concentrated protein solutions such as serum are incessantly
bombarded with protein molecules. There are multiple protein
binding sites on the NPs with rather heterogeneous binding
strengths [36,139]. In a first step, a properly folded protein engages
in a weakly and reversibly bound complex with the NP, character-
ized by relatively fast adsorption and desorption kinetics. In a
second step, structural adjustments occur at the interface that lead
to persistent attachment of the protein to the NP surface. These
adaptations are slow, especially if they involve major conforma-
tional rearrangements of the polypeptide chain (local or global
denaturation), and they can only take place if the protein remains at
the binding site for a significant fraction of time. Upon NP immer-
sion in highly dilute protein solutions, only a few binding sites (or
just a single one) on the NP may be appreciably populated for
subsequent conformational changes to occur. Under these condi-
tions, protein-protein interactions are absent and the loosely
adsorbed protein may fully denature, flatten and spread over a
large area [140], thereby establishing strong, irreversible in-
teractions with the NP surface and also occluding binding sites for
other proteins (Fig. 4). With increasing protein concentration,
successively more binding sites become populated and perma-
nently adsorb proteins, so the binding curve rises continuously
according to a binding isotherm. Interactions of proteins with their
simultaneously present neighbors becomemore important that can
restrict structural changes and modify the overall binding
strengths. This cooperativity affects the steepness of the binding
curve. At high protein concentrations, the extent of protein
spreading is severely restricted by neighboring proteins. We noteFig. 4. Mechanistic scheme of protein adsorption onto charge-stabilized, hydrophobic
NPs. (I) Upon initial contact, the protein (represented by an oval with hydrophobic core
(blue) and hydrophilic (red) shell) and the NP (assumed to have a hydrophobic surface
(blue) and charged functionalized groups (red)) form a weakly and reversibly bound
complex with fast protein adsorption and desorption. (II) The protein residing on the
NP may change its conformation and (III) partially unfold to expose its hydrophobic
core. Electronic repulsion between neighboring proteins may affect the affinity to-
wards the NP. (IV) Strong hydrophobic interactions establish an irreversible complex.
Bound water (hydration shells), which has to be removed when the NP-protein
interface forms, has not been included in this scheme. Adapted from Ref. [72].that, in this regard, the adsorption of polypeptide chains shares
analogies with the well-studied grafting of end-functionalized PEG
chains to solid substrates [141,142]. Importantly, the final confor-
mational state of the adsorbed proteins and, therefore, the struc-
ture of the protein corona depends on the balance between the
protein's internal stabilization energy on the one hand and the
strengths of proteineNP and proteineprotein interactions on the
other hand. Indeed, the sharp agglomeration transition (Fig. 3a and
b) suggests that dense grafting of proteins to NP surfaces (at high
concentration) limits the extent of conformational change. Taken
together, the “binding isotherms” observed for irreversible
adsorption thus reflect the population of transient binding sites
from which persistent adsorption occurs.
The dependence of the corona structure on the concentration of
biomolecules in the fluid has important implications for engi-
neering strategies of NPs for biomedical applications that utilize
pre-adsorption of proteins for surface passivation or functionali-
zation. If the adsorption layer forms at high protein concentration
(e.g. in serum), dense grafting of the proteins will have a stabilizing
effect, and the solvent-exposed protein shell is likely to retain
native-like structure, and further proteins are not likely to adhere
under physiological conditions due to their colloidal stability. If,
however, a hard layer is formed at low protein concentration,
polypeptide chains spread on the NP surface and expose hydro-
phobic moieties, and other proteins may possibly associate with
this partially decorated hydrophobic surface.
4. Nanoparticle engineering for control of the protein corona
To successfully engineer NPs for biomedicine, researchers have
to anticipate the ensuing interactions within the biological system,
which modify the NP surface and determine its cellular uptake,
intracellular trafficking, pharmacokinetics, biodistribution and
toxicity [24]. NPs functionalized with targeting ligands such as
antibodies, peptides, sugars and proteins might lose their targeting
capability when a protein corona forms on their surface and oc-
cludes those ligands [143]. Moreover, the immune system features
potent molecular tools that canmodify surfaces that are recognized
as non-self, and binding of opsonins (antibodies, complement
components) to the corona can significantly enhance recognition
and clearance by the mononuclear phagocyte system [144e146].
A straightforward strategy to cope with the complexity of NP
interactions within the living system appears to be suppression of
protein corona formation by using zwitterionic surface function-
alization or dense decoration with hydrophilic polymers such as
PEG brushes or carbohydrates [147]. The ‘stealth effect’ of the NPs
toward the immune system gives rise to extended circulation times
in the bloodstream that improves the efficacy of nanomedicines.
Considerable efforts have been directed toward the design of such
highly hydrophilic coatings with low affinity for any type of protein
[148e151]. However, experiments have shown that complete
resistance to protein adsorption seems to be difficult if not
impossible to achieve [91]. Moreover, the additional decoration of
these NPs with targeting moieties is likely to enhance immune
recognition.
Alternatively, if protein adsorption cannot be avoided by any
means, onemay devise strategies to control the amounts, types and
orientations of the proteins (and other (bio)molecules [152e155])
adsorbing from the biofluid [37,39,44,156e162]. Thus, the protein
corona is not considered an obstacle, but rather an opportunity to
achieve selective biological responses by specific preparation, e.g.
by pre-adsorbing specific proteins or by using NP surface coatings
that preferentially bind certain proteins from the biological envi-
ronment. For example, pre-adsorption of opsonins as part of the
corona can enhance recognition and clearance by phagocytes
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apolipoproteins and albumin onto the NP surfaces can suppress
phagocytic uptake and thus induce a stealth effect [39,163].
Particular plasma proteins in the corona may improve delivery to
specific organs [164,165] or specific tumor cells [166,167]. It has
been shown, for example, that apolipoprotein E is essential for
some siRNA lipoplexes to target hepatocytes in vivo [168].
Caruso and co-workers [169] have summarized the effects of the
complex biological environment on the targeting ability of NCs,
with a special focus on the impact of the protein corona, and
include strategies for tuning the corona by design to balance the
stealth effect with the targeting capability. In the following, wewill
present recent studies that exemplify how engineering of the NP
surface can exploit the protein adsorption tendency to endow the
NPs with beneficial properties as nanomedicines.
4.1. Opsonization of adsorbed proteins by the complement system
Cells of the immune system continuously scan the organism for
foreign materials in order to recognize pathogens and to remove
them from the organism. Indeed, NPs become internalized by blood
leukocytes and tissuemacrophages upon intravenous injection. The
complement system, an essential component of the innate immune
system, consists of more than 30 plasma proteins and assists in the
recognition of NPs by phagocyting immune cells. C3, a protein
present in human plasma at a concentration of ~5 mM [170], plays a
key role in this process. From the three complement activation
pathways, only the alternative pathway is relevant here [171]. It
involves spontaneous hydrolytic cleavage of C3 into two fragments,
C3a and C3b (more precisely, a C3b variant denoted C3(H2O)),
which occurs at low rate (0.005%/min) so that, at any given time,
~0.5% of C3 molecules are present in the fragmented form [172].
C3b binds another protein, namely fragment Bb of complement
factor B, from the serum to form the alternative pathway C3 con-
vertase, which is stabilized by properdin, an essential protein factor
of complement activation via the alternative pathway. This enzyme
catalyzes hydrolysis of further C3 molecules into C3a and C3b, the
latter of which contains a highly reactive thioester group through
which it can covalently bind to nucleophilic groups, e.g. amines or
hydroxyls, on the surface of an activating moiety. C3 and C3b are
potent “eat me” signals (opsonins) for tissue macrophages and
blood leukocytes; therefore, a protein-coated NP presenting C3 to
complement receptors on leukocytes will enhance phagocytosis.
For drug delivery, hitchhiking of NPs in these cells to target sites
could be a possible way to overcome biological barriers en route to
the target [144]. Alternatively, NP surfaces suppressing C3 or C3b
adsorption reduce immune recognition and the accompanying
adverse effects, and the extended availability in the organism can
greatly improve the targeting and efficacy of drug NCs.
Simberg and coworkers [144,173] explored the role of the
complement system in leukocyte recognition and uptake of
dextran-coated superparamagnetic iron oxide (SPIO) NP chains, so-
called nanoworms (NWs). SPIO is an important material for mag-
netic resonance imaging and has also been used to fabricate
multifunctional NPs for theranostic applications [174]. The NWs
were found to be exclusively recognized by (human and mouse)
leukocytes and platelets through their opsonization with C3. Their
uptake by leukocytes was abolished by EDTA, a complement in-
hibitor, and by an antibody binding to and thereby inactivating
properdin. In-vivo experiments with C3-deficient mice further
demonstrated the crucial involvement of C3. Conversion of the
dextran shell of the NWs to a hydrogel layer by crosslinking with
epichlorohydrin resulted in a strong suppression of NW internali-
zation by leukocytes, exemplifying how immune recognition can be
greatly modulated by NP surface engineering. TEM revealed thatthe adsorbed proteins were localized within the ~70 nm thick
dextran shell of the NWs [173]. Interestingly, the opsonizing frag-
ment C3bwas covalently linked to adsorbed proteins and not to the
dextran shell and underwent exchange with these proteins in vitro
and in vivo.
In a follow-up study, Simberg and coworkers discovered that
immunoglobin G (IgG) plays a key role for mediating C3 opsoni-
zation [145]. Specifically, they observed that IgG depletion from
human plasma samples decreased C3 deposition onto SPIO NWs
(and also on several clinically approved nanomedicines). For all
these nanomaterials, C3 opsonization could be restored by adding
polyclonal human IgG. To determine whether IgG simply acts as a
C3 binding scaffold, the hard corona (formed by 30 min incuba-
tion at 37 C in 75% plasma) was eluted from SPIO NWs and
analyzed by using non-reducing SDS-PAGE. The gel clearly
showed the presence of IgG-C3 complexes. Notably, the C3 con-
centration in the corona was ~50-fold higher than that of IgG,
indicating that many other proteins had been opsonized as well.
From their study, the authors derived the following model of
opsonization (Fig. 5). Initially, IgG molecules recognize and bind
specific epitopes on the protein corona. For example, these could
be cryptic epitopes that are usually hidden in the interior of the
protein and only become exposed to the surface upon denatur-
ation. IgG molecules may either bring in C3b docked to a specific
site on their Fc fragment, or associate with C3b after binding to
corona proteins. The C3 convertase (C3b/Bb/properdin) assembles
on the NP surface and locally catalyzes C3 hydrolysis, producing
further highly reactive C3b for opsonization of other corona
proteins. Because of this amplification, a few initially present IgG
molecules (or even only a single one) anchoring C3b may suffice
for efficient opsonization.
Therefore, this mechanism calls for the development of effective
strategies to control binding of antibodies onto NPs. On the one
hand, pre-coating with antibodies presenting their Fc fragment on
the surface can enhance targeting of leukocytes via enhanced C3
opsonization. On the other hand, to create NPs that evade immune
system recognition and, thereby, removal from the system via
phagocytosis, binding of antibodies from bodily fluids to the bio-
molecular corona must be suppressed, for example, by protein-
repellant surfaces (zwitterionic coatings or stealth polymers), or
by pre-coating with dysopsonins.
4.2. Corona engineering to prevent immunoglobulin adsorption
About 20% of the blood proteome are Ig molecules; among
these, IgG is the most prominent isotype [175]. IgG levels depend
on the health status of a patient and can be elevated due to infec-
tion, inflammation, autoimmunity or malignancy. Thus, intrave-
nously injected NPs can encounter varying lgG concentrations in
the circulation, which can potentially lead to varied biological re-
sponses. As IgG molecules adsorbed to NPs play a key role in the
opsonization of NPs by the complement system, an important
strategy to enhance the lifetime of NPs in the system is to engineer
their surfaces so as to reduce IgG adsorption, thereby enhancing the
probability that a drug delivering NP reaches its tumor target.
In their recent study of adsorption of human plasma proteins
onto PEG- and poly(ethyl ethylene phosphate) (PEEP)-modified PS
NPs, Sch€ottler et al. [39] found that these polymer coatings change
the protein composition (with respect to aminated NPs) toward
apolipoproteins, predominantly clusterin (apolipoprotein J). NP
uptake by RAW246.7 macrophages was strongly suppressed if the
NPs were first immersed in human plasma, indicating that an
additional component from plasma was required to convey a
stealth effect to the NP surfaces. Clusterin was identified as being
mainly responsible for the strongly dysopsonizing effect.
Fig. 5. Complement activation by IgG molecules via the alternative pathway. IgG molecules binding to the biomolecular NP corona are opsonized by spontaneously formed C3b
molecules. The C3 convertase complex (C3b-Bb, stabilized by properdin (P)) assembles and catalyzes cleavage of serum C3 and covalent attachment of additional C3b molecules on
the corona. Adapted with permission from Ref. [145].
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prevents macrophage uptake, Prozeller et al. [176] compared the
protein corona formed by 1-h immersion of (non-covalently)
PEGylated PS NPs and hydroxyethyl starch nanocapsules (HES-NCs)
with and without prior coating with clusterin in fivefold diluted
human plasma solution. Moreover, they studied the effect of IgG-
enrichment (by a factor of 2) in the solution (Fig. 6a). The protein
composition of the hard corona formed on the NP surfaces was
analyzed via liquid LC-MS. For incubation with regular plasma,
clusterin (38.8%) and apoA-I (19.4%) (PS-NPs), and clusterin (43.2%)
and apoE (8.4%) (HES-NCs) were the two predominant proteins in
the coronae. Remarkably, doubling of the IgG concentration led to
an enormous increase of the IgG fraction in the corona by a factor of
40 for both NP types (Fig. 6b). Similar observations were made for
other nanomaterials, suggesting a general effect. Moreover, the
total mass of adsorbed protein almost doubled upon immersion in
IgG-enriched plasma. Pre-coating with clusterin (10 min, ~250 nM
in PBS) before immersion in the IgG-enriched plasma, however,
again yielded a protein composition similar to the one obtained
with regular plasma (Fig. 6b).
Comparison of the three different incubation procedures shows
the crucial effect of clusterin in suppressing IgG in the protein
corona. In normal plasma, IgG is much more abundant (~16 mM in
fivefold diluted plasma) than clusterin (~250 nM). In the protein
corona formed around these polymeric NPs, however, clusterin is
enormously enriched with respect to IgG. Remarkably, the clusterin
effect is not effective in twofold IgG-enriched plasma but can be
largely restored by pre-incubation with clusterin. Apparently, the
greater IgG concentration largely blocks clusterin access to the
surface. This is an interesting effect; its strong concentration
dependence is reminiscent of the sharp transition in the agglom-
eration experiments with hydrophobic PS NPs (see subsection
3.3.2.), which are also related to blocking of the surface by dense
grafting at high protein concentration.
Uptake into murine and human macrophages was markedly
increased upon NP incubation with IgG-enriched plasma, demon-
strating the opsonizing effect of IgG molecules [176]. It remains tobe uncovered whether complement activation can also amplify the
phagocytosis in response to these NPs, as discussed in the previous
subsection.
In conclusion, modest variations in the IgG fraction of the bio-
fluid have been shown to induce drastic changes of the protein
corona composition. Clusterin enrichment in the protein corona
may be a powerful means to reduce the influence of varying blood
compositions between individuals on the outcome of nano-bio
interactions. In protein corona engineering, this objective can be
reached either by pre-coating with clusterin or by coating the NPs
with surfactants that preferentially adsorb this protein [176].
4.3. Corona design by using specific protein binding
NP surface decoration with antibodies that recognize epitopes
specific to (or at least more abundant on) target cells, or with li-
gands that are recognized by receptors overexpressed on target
cells, is a conceptually simple strategy for engineering NPs for de-
livery of drugs to specific sites, e.g. tumors. Often, however, tar-
geting moieties are not presented in the correct orientation at the
surface or may become covered by proteins adsorbing onto the NP,
so that targeting is dysfunctional [143]. For example, Tf is an
important protein for iron homeostasis of a cell and abundant in
blood. It binds to the Tf receptor on the cell membrane, which
triggers its cellular uptake to deliver iron ions. Still, NP uptake by
cells was strongly suppressed by Tf incubation [177], and the tar-
geting specificity of Tf tethered to silica NPs was completely lost
upon serum exposure due interference by the additional protein
corona [143]. Therefore, great care has to be taken that targeting
epitopes are presented on the NP surface (in the presence of a
protein corona!) in such a way that their cognizant receptors can
efficiently interact with them.
Tonigold et al. [159] explored how pre-adsorption of NPs with
antibodies can be used to endow them with targeting moieties,
ensuring their accessibility, correct orientation and flexibility to
enable interactions with the cell surface in the presence of protein
adsorption. They attached similar amounts of functional anti-CD63
Fig. 6. (a) Corona formation on NCs incubated in normal plasma (top) and IgG-
enriched plasma (middle, bottom) before (top, middle) and after (bottom) pre-
coating the NC surface with clusterin. (b) Composition of the protein corona of PS NPs
after incubation with normal plasma, IgG-enriched plasma or IgG-enriched plasma
after pre-incubation with clusterin analyzed via LC-MS (normalized for protein
amounts). Adapted with permission from Prozeller et al. [176].
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or by covalent coupling via amines on the antibody surface with a
random orientation. NPs with chemisorbed antibodies showed less
internalization by monocyte-derived dendritic cells, suggesting
that their randomly oriented antigen binding domains were only
partially recognized by CD63 proteins in the cell membrane.
Cellular uptake of NPs with physisorbed antibodies was unaffected
by protein adsorption. The authors suggested that selective
unfolding of the CH2 region of the antibody's Fc fragment can lead
to the observed strong attachment to the NPs in an orientation
presenting both antigen binding (Fab) fragments on the hydro-
phobic NP surface. From these results, we can conclude that the
serum protein corona cannot be thicker than the extension of a Fab
fragment, (~7 nm), in agreement with the experiments discussed in
subsection 3.3.1. The pre-adsorption strategies used by Tonigoldet al. [159] may be simple yet effective. More sophisticated strate-
gies for covalent attachment in specific orientations involve
genetically engineered antibodies (single-chain Fv or Fab fragments)
[178] or affibodies (Afbs), engineered antibody mimetics, as
exemplified in the following subsection.
4.4. Corona design using engineered proteins
Molecular biology offers an elaborate toolbox, from which pro-
teins can be tailor-made to form a protein shroud with precise
design of the surface moieties. A simple design for this purpose is a
fusion protein featuring two domains, one having a high affinity for
functional groups on the NP surface, and the other one having a
high affinity for targeting epitopes. If these proteins are pre-
adsorbed under suitable conditions, they will form a shell of folded
proteins that may even be recognized as “self” by the immune
system.
Oh et al. [179] presented an example of how such an engineered
protein corona around a NP can provide excellent targeting ability.
Glutathione (GSH)-functionalized mesoporous silica nanoparticles
(MSNs), referred to as GSH-MSNs, were coated with a fusion pro-
tein consisting of glutathione-S-transferase (GST) and an HER2-
binding affibody (HER2-Afb). The GST domain binds GSH with
high affinity and thus serves to attach the protein to the MSN. The
HER2-Afb binds to the tyrosine kinase receptor HER2 with high
affinity [180]. HER2 is a member of the human epidermal growth
factor receptor family and is overexpressed in tumor cells of several
types of cancer, including an aggressive form of breast cancer [181].
Therefore, this domain serves as a device to target cancer cells.
MSNs with the GST-HER2-Afb protein decoration (protein
corona shield nanoparticles (PCSNs)) and GSH-MSNs and PEG-
modifiedMSNs (PEG-MSNs) as controls were incubated for 1, 2, and
4 h in 55% fetal bovine serum (FBS). Then, unbound protein was
removed by centrifugation, and the compositions of the hard pro-
tein coronae were analyzed by sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis (SDS-PAGE). Compared to GSH-
MSNs and PEG-MSNs, PCSNs showed ~15-fold lower adsorption
of serum proteins, regardless of the incubation time. In the PCSN
corona, the relative concentration of apolipoproteins was higher
than in the control samples, while the amount of proteins involved
in immune responses was lower, suggesting longer circulation
times of the PCSNs.
To evaluate whether the PCSNs can evade internalization by
phagocytic cells, the murine macrophage-like cell line RAW264.7
was exposed to DiI-loaded PCSNs and PEG-MSNs for 6 h. NPs were
pre-incubated with 55% FBS for 4 h. Confocal microscopy showed
more than 10-fold lower cellular uptake of PCSNs compared to PEG-
MSNs, demonstrating the stealth effect of the protein shield
(Fig. 7a). To examine cell-specific targeting via the HER2-affibody,
HER2-receptor-overexpressing SK-BR3 cancer cells and receptor-
free HEK293T cells were exposed to DiI-loaded PCNs for 4 h. Up-
take was only observed for the SK-BR3 target cells, indicating that
the targeting functionality was retained.
To test the PCSNs on an in-vivo tumor model, PCSNs and PEG-
MSNs as control were injected into the tail vein of nude mice
bearing SK-BR3 cell xenografts. Already 30 min after injection, in-
vivo live fluorescence imaging revealed a 1.8-fold higher emission
intensity in tumor sites of the PCSN-treatedmice compared tomice
treated with PEG-MSNs. The PCSN emission persisted for 24 h,
while the signal of the PEG-MSNs gradually decreased. In addition,
the PCSN fluorescence signal in the tumor was seven-fold higher
than that in reticuloendothelial organs, while there was no differ-
ence for the control particles (Fig. 7b). Therefore, the engineered
protein corona enabled the NPs to evade the immune system due to
the reduced protein adsorption and to accumulate in the target
Fig. 7. (a) The engineered protein corona shield (PCS) retains the NC targeting ability by inhibiting blood protein adsorption. (b) Fluorescence images of organs and tumors 48 h
after intravenous injection of PEG-MSNs and PCSNs and biodistribution of injected NCs in animals with SK-BR3 tumor xenografts (obtained from fluorescence intensity analysis).
Adapted with permission from Ref. [179].
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anticipate that it will be extended to other affinity tags and anti-
body constructs in the future.
5. In-vivo experiments to study corona formation
Recent years have seen a vast number of in-vitro studies aimed
at characterizing protein corona formation on NPs, often using cell-
culture media, serum, plasma or whole blood. We note that the
source of the biofluid (e.g. mouse or human) and even the process
to isolate a biofluid for in-vitro studies (e.g. blood with or without
ethylene diamine tetra-acetic acid (EDTA), serum or plasma) may
cause decisive differences in the composition of the protein coronaaround NPs [15,182,183]. The expectation within the field is that
these huge compilations of data will eventually lead to a profound
mechanistic understanding of protein adsorption that allows re-
searchers to predict from in-vitro studies what happens in the real
biological environment. This lack of in-vitro methods to predict in-
vivo consequences has been identified as one of the key obstacles
towards efficient translation of biomedical NPs from the bench to
the clinic [184]. The problem is rooted in the bewildering
complexity that an organism offers to internalized NPs.
To illustrate the complexity, there are different ways in which
NPs may enter the human body, via injection into the bloodstream,
via inhalation through the lungs, through contact with the skin, or
through the gastrointestinal tract after ingestion. These entry routes
K. Nienhaus et al. / Materials Today Advances 5 (2020) 10003614offer distinctly different environments to the NPs, with different
amounts and types of biomolecules, different pH and ionic strengths
[185]. Upon exposure to biofluids, NPs will immediately be coated
with proteins and, on its journey through the body, the corona will
evolve due to its own slow dynamics and the ever-changing phys-
iological environment, e.g. when a NP leaves the capillary to
transgress the blood-brain barrier [186,187]. NPs in the body expe-
rience dynamic flow, which introduced shear forces that are typi-
cally not present in in-vitro experiments [17,41,188,189]. This
dynamic nature of the environment must be taken into account to
be able to reliably predict the outcome of NPeprotein interactions
[190]. Even the health status of an individual may modulate the
protein corona (‘personalized protein corona’ [191]) and the efficacy
of nanomedicines [192], as already discussed in subsection 4.2.
A crucial first step toward the prediction of in-vivo coronae is to
characterize them and to compare themwith those formed in vitro.
For example, NPs are injected into the tail vein of a mouse and
subsequently recovered from bloodwithdrawn by cardiac puncture
at specific time points after administration [193,194]. During the
following ex-situ proteomics analysis, only persistently binding
proteins will be retained; loosely bound biomolecules will be lost,
although they may be important for the in-vivo fate of the NPs.
Thus, there is a need for techniques enabling in-situ analysis of the
protein composition [195], as is also the case for in-vitro studies. At
this point in time, in-vivo studies are still scarce. In the following,
we discuss recent progress in the in-vivo application of NPs in the
context of protein adsorption.
5.1. Comparing in-vitro vs. in-vivo corona formation
Kostarelos and coworkers [196] found significant differences in
the relative abundances of proteins in the coronae formed on
PEGylated liposome NPs (diameter ~ 120 nm, with and without
attached antibodies for targeting) that were either incubated for
10 min in CD-1 mouse plasma or recovered from CD-1 mice 10 min
after intravenous injection, with a greater variety of protein species
in the in-vivo corona. In follow-up work focusing on the time evo-
lution of the corona [197], the total amount of adsorbed proteins
(determined by a colorimetric assay) remained constant over 3 h,
whereas the relative amounts of different proteins changed consid-
erably, reflecting the dynamic nature of the protein corona (Fig. 8).
Wang et al. [198] compared the uptake of dextran-coated SPIO
NWs in vitro (by peritoneal macrophages) and in vivo (by leukocytes
in mice). They reported that SPIO NWs that were crosslinked with
epichlorohydrin to reduce opsonization by C3 showed little uptake
by mouse peritoneal macrophages in vitro. Additional functionali-
zation with PEG antibodies had essentially no effect on the in vitro
uptake but increased the level of complement-dependent in-vivo
uptake by leukocytes in mice. They also showed that using fresh
mouse lepirudin plasma instead of serum improved the correlation
between the in-vitro and in-vivo outcome.
As protein corona formation may affect the targeting ability of
engineered NPs (see section 4.3.), Zhang et al. [160] incubated PS
NPs functionalized with Tf receptor targeting ligands (DT7 and LT7
peptides, Tf) for 1 h in humanplasma and, for comparison, collected
plasma samples frommice 10 min after intravenous injection of the
NPs. Uptake experiments in HepG2 cells overexpressing Tf re-
ceptors showed that the targeting capacity was lost after incuba-
tion with plasma in vitro, whereas it was partially retained after in-
vivo corona formation.
5.2. In vivo corona formation
Corbo et al. [199] compared the temporal evolution of the
protein corona around leukosomes and control liposomes(~170 nm diameter each), and also their uptake by macrophages.
Leukosomes are liposomes with leukocyte membrane proteins,
including IgG receptors, coagulation factors, and complement
proteins, introduced in the liposomal lipid bilayer to obtain NPs
mimicking the activity of natural leukocytes. Both types of NPs
were injected into the tail vein of healthy mice; blood was
withdrawn by cardiac puncture 10 min and 1 h after injection and
the proteins adsorbed to the liposomes were identified by MS.
Overall, leukosomes adsorbed fewer protein types than lipo-
somes. One of those, clusterin, was exclusively found in the leu-
kosomal corona. Interestingly, the protein corona formed in vivo
increased the uptake of liposomes by immune cells but decreased
the uptake of leukosomes. The authors suggested that the inter-
action of IgGs and other corona proteins with the receptors on the
leukosomes prevented them from binding to their receptors on
the macrophages.
Recently, Hadjidemetriou et al. [200] presented a proof-of-
concept clinical study on in-vivo corona formation onto PEGylated
liposomal NPs in humans, which had been infused intravenously
into patients with recurrent ovarian carcinoma. Protein-coated li-
posomes were subsequently recovered from the blood, separated
from blood components, and the adsorbed proteins were qualita-
tively and quantitatively analyzed. The most abundant protein
classes were Igs, lipoproteins, and complement proteins, in agree-
ment with an earlier study on mice [197]. Moreover, more protein
species were identified in the in-vivo corona than in its counterpart
ex-vivo corona. Interestingly, the most abundant serum protein,
albumin, was essentially absent from the in-vivo corona. Instead,
low-abundance, low-molecular weight proteins were present. In a
subsequent study, liposomal NPs were used as tools to fingerprint
the blood proteome [201]. PEGylated liposomeswere intravenously
administered to subcutaneous melanoma-bearing and lung carci-
noma xenograft-bearing mice. Recovery and purification of the
corona-coated liposomes from the blood circulation of the two
mice models enabled the detection of tumor-released and thus
tumor-specific proteins of low abundance, which were not
noticeable in plasma samples obtained by cardiac puncture of
healthy and tumor-bearing mice (w/o prior NP injection) because
they were masked by highly abundant plasma proteins such as
albumin. The liposomal NPs even allowed murine host response
proteins and human inoculated tumor-released proteins of minor
abundance to be detected concurrently in the xenograft model.
Temperature-sensitive liposomes (TSLs) are sophisticated drug
carriers that release their cargo in response to the higher tem-
perature inside the tumor interstitium or the vasculature/blood
[202]. Al-Ahmady et al. [203] investigated the effects of protein
corona formation on their release activity. They administered the
TSLs via intravenous injection into the tail vein of CD-1 mice and
recovered those 10 min later from the blood. Afterwards, the drug
release kinetics was determined ex situ, both in full plasma and
after separation of unbound and weakly bound proteins. This
study showed that the in-vivo corona had a dramatic impact on
the drug release profile, the extent of which varied with the TSL
lipid composition and the protein content of the environment.
Therefore, it is crucially important to take these effects into ac-
count in the engineering of TSLs and the applied temperature
protocols.
6. Conclusions and perspectives
The road toward routine fabrication of nanomaterials for diag-
nostic or therapeutic applications is a long and arduous one.
Currently, only a few types of NPs have been approved by the US
Food and Drug Administration (FDA), mostly for cancer therapy,
and a few more are in the approval pipeline [204]. The essentially
Fig. 8. In-vivo investigation of the protein corona as a function of time. (a) Work flow: Liposomes were intravenously administered via tail vein injection into CD-1 mice and
recovered by cardiac puncture 10 min, 1 h and 3 h after injection. After separating the plasma from the recovered blood by centrifugation, the protein-coated liposomes were
separated from unbound proteins. The compositions of the protein coronae formed at the different time points were qualitatively and quantitatively characterized and compared.
(b) Total amount of proteins adsorbed on liposomes recovered 10 min, 1 h and 3 h after injection (average and standard error from three independent experiments). (c) Venn
diagram showing the numbers of unique proteins identified in the in vivo corona at the different time points and their respective overlap. Adapted from Ref. [197].
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properties of the as-prepared NPs from those that are relevant in
the biological setting, making predictions of functional behavior in
the real biological environment exceedingly challenging. In recent
years, awealth of studies has been devoted to the exploration of the
protein corona, and we are slowly and steadily learning more about
its complexity and the implications for biological responses,
including safety and toxicity issues and, importantly, efficacy of
nanomedicines. Although significant progress has been made over
the last decade, our understanding of the structure, composition
and time evolution of the corona around NPs at the molecular scale
is still at an early stage. This raises questions about the strategies
that may ensure swift progress in the field.
In our view, it is important to deepen our fundamental under-
standing of the detailed processes involved in corona formation. As
we have emphasized in this work, even elementary issues
(monolayer/multilayer, softness/hardness) are still under debate.
We believe that the enormous complexity associated with theprocesses at the nano-bio interface is still not sufficiently appreci-
ated by many researchers in the field. Proteins are typically viewed
(and schematically depicted) as compact, globular moieties when
in fact they may turn into grossly denatured polypeptide chains
under the influence of only moderate perturbative forces exerted
by the NP surface. A deep understanding of the protein corona
implies that we require knowledge of the optimal (free-energy
minimized) architecture of polypeptide chains interacting with the
NP surface (and their neighboring chains on the NP surface). To this
end, different processes need to be scrutinized at the molecular
level, including protein adsorption and desorption, conformational
changes, surface migration, also in the presence of other and
different polypeptides, polypeptide competition resulting in ex-
change (Vroman effect), and so on. Such studies are demanding,
and conventional experimental techniques can yield only limited
insight (see section 3). Novel single molecule/particle-based
methods have the potential to enable entirely new views on the
protein adsorption problem, and especially techniques that enable
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invaluable. Furthermore, molecular-level computer simulations
will be most helpful for advancing the field, and we believe that
such activities will intensify in the upcoming years. This involves
the development of specific computational tools for this purpose,
which should be guided by e and calibrated with e experimental
studies on well-defined model systems. To summarize, the struc-
tural exploration of the protein corona at the molecular level will
continue to be a fascinating area of research with important im-
plications for nanobiomedicine.
In the coming years, the efforts by many labs all over the world
to design and synthesize new NPs will continue and presumably
even intensify. It should be appreciated that nanomaterials for
biomedical applications must possess highly defined properties
and batch-to-batch reproducibility. This, in turn, requires reliable
methods and procedures for the assessment of their physico-
chemical properties. For NP as well as protein corona character-
izations, it would be useful if standardized experimental conditions
could be defined that facilitate comparison of data from different
labs. For technical reasons, the analysis of biomolecular adsorption
onto NPs has mainly focused on proteins due to the availability of
powerful proteomics methods but need to be extended to other
types of biomolecules as well.
An enormous amount of data regarding protein corona forma-
tion on a wide variety of NPs under a wide variety of conditions has
been amassed. To keep track of all these experimental data and to
further utilize them for computational analysis, databases need to
be assembled that include physicochemical characterizations of
both the NPs and the protein coronae. Importantly, these data are
only useful if procedural parameters are also reported in great detail,
so that experiments can be reproduced or compared with other
ones. Indeed, the varying standards of reporting in scientific publi-
cations in thefield have been criticized, and guidelines forminimum
information reporting have been proposed to ensure that all rele-
vant procedural details have been made available [205,206]. On the
basis of precise and highly reproducible data, the complex relations
between NP properties, reaction conditions and the resulting pro-
tein corona composition and properties can be analyzed using
computational models to yield qualitative and quantitative
structureeactivity relationships (SARs) [207,208]. Perhaps, machine
learning algorithms, trained with extensive and reliable data com-
pilations, may enable predictions of the biological response without
even understanding the underlying processes [209].
Researchers are becoming increasingly aware that in-vitro
studies of protein corona formation and the assessment of biolog-
ical responses in cell cultures may have deficiencies that prevent
predictions of the behavior of protein coated NPs in the real bio-
logical environment. Therefore, studies employing complicated in-
vitro environments will intensify, including more complex cell
cultures, e.g. organoids, and flow reactors that simulate, e.g. the
blood circulation. Nevertheless, in-vivo testing of engineered NPs
using animal models will remain an essential step toward closing
the translational gap in nanobiomedicine.
In conclusion, to understand biomolecular adsorption onto
nanoparticles in sufficient depth so that biological outcomes can be
predicted, much progress is still needed. Enormous challenges lie
ahead on this road, but the ultimate goal, i.e. gaining the ability to
design highly specific and effective, perhaps even patient-specific
tools for nanomedicine, is certainly worth the effort.
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